MedTech Solutions, a company listed on NewConnect and developing a scalable business model in the distribution of medical devices and technologies, is entering the surgical robotics segment by introducing the MISSO system for orthopaedic procedures to the Polish market.
The partnership with global manufacturer Meril Life gives the company access to the fast-growing medical robotics segment and sales exclusivity in Poland, excluding Meril’s own structures, for a period of up to five years. This significantly strengthens MedTech Solutions’ position in this area and diversifies its revenue sources.
Entering the distribution of robotic systems gives the company an opportunity to increase the value of individual contracts and develop sales based on higher-unit-value products. At the same time, the distribution-based business model allows MedTech Solutions to use its existing network of hospital relationships and accelerate the commercialisation of the new segment.
MISSO is an advanced robotic system that supports surgeons in performing orthopaedic operations, particularly joint replacement procedures. The technology combines precise surgical planning based on 3D imaging with accurate execution tailored to the patient’s anatomy.
The system actively supports the physician during surgery by analysing the course of the procedure in real time and enabling adjustments. Thanks to advanced sensors and optical tracking, sub-millimetre precision can be achieved, resulting in better implant fit and greater repeatability of outcomes. Compared with traditional methods, the system reduces dependence on manual tools and fits into the broader trend of surgical automation.
MISSO also stands out for its high level of automation. It takes over some of the most demanding stages of the procedure, reducing the risk of errors and increasing procedural safety. From the patient’s perspective, this may mean a less invasive procedure, reduced post-operative discomfort and a faster return to mobility.
“The implementation of MISSO increases contract value and improves margins, while accelerating conversion of the sales pipeline. We rely on our existing relationships with hospitals and distribution infrastructure, which shortens time-to-market and supports the scaling of our operations. We estimate that the potential use of such systems in Poland covers around 30 facilities and 3,000 procedures annually, which shows the scale of possible growth in this segment. As a result, we increase revenue predictability and build exposure to a high-growth segment. This is one of our key development directions for the coming years,” said Jarosław Kaim, President of the Management Board of MedTech Solutions.
A key element of the sales model is flexible financing, including leasing, which shortens the decision-making process for hospitals and increases access to the technology. Combined with a competitive price level compared with Western solutions, this should allow faster scaling of system sales.
Under the cooperation with Meril Life, MedTech Solutions is responsible for market development and distribution of the MISSO system in Poland. This enables the company to expand sales and build a stable project pipeline in the surgical robotics segment.
The surgical robotics market in Poland is in a phase of dynamic growth. Its value is expected to increase from around PLN 624 million in 2023 to more than PLN 2.1 billion in 2028, which represents a compound annual growth rate of approximately 28%. At the same time, most procedures are still performed without robotic support, indicating significant potential for further development of this segment.
Entering the distribution of robotic systems is an important element in building MedTech Solutions’ long-term position in modern medical technologies and supports the company’s further growth.
The portfolio expansion is in line with the company’s strategy of scaling revenue through the development of new product categories. In parallel, MedTech Solutions is developing its own solutions and AI technologies, financing the expansion of additional segments from current operating activities.
